Marshall Financial Group, LLC

Position in AMGN — Amgen Inc

CIK 1841496 Hunt Valley, MD

Position in AMGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$2,439,240

+$320,048 QoQ

Shares Held

6,736

+11.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

#1,165

of 3,140 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Marshall Financial Group, LLC holds $15,627,500 across 8 Drug Manufacturers - General names. AMGN ranks #4 (15.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	35,820	$4,602,870
2	NVS	Novartis AG	17,632	$2,763,287
3	JNJ	Johnson & Johnson	10,123	$2,570,938
4	AMGN	Amgen Inc This page	6,736	$2,439,240
5	LLY	ELI LILLY & Co	1,613	$1,934,680
6	AZN	Astrazeneca PLC	4,153	$787,491
7	NVO	Novo Nordisk A S	5,607	$268,799
8	ABBV	AbbVie Inc.	1,034	$260,195

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,439,240	6,736	+11.8%	Shares	Sole	2026-07-20
2026-03-31	$2,119,192	6,023	+2.4%	Shares	Sole	2026-04-13
2025-12-31	$1,924,255	5,879	+665.5%	Shares	Sole	2026-01-09
2025-03-31	$239,270	768	-19.7%	Shares	Sole	2025-04-16
2024-12-31	$249,432	957	-75.2%	Shares	Sole	2025-01-21
2024-09-30	$1,242,119	3,855	+2.8%	Shares	Sole	2024-10-16
2024-06-30	$1,171,999	3,751	+4.5%	Shares	Sole	2024-07-19
2024-03-31	$1,020,708	3,590	+9.3%	Shares	Sole	2024-04-19
2023-12-31	$945,857	3,284	-1.7%	Shares	Sole	2024-01-10
2023-09-30	$898,195	3,342	+0.3%	Shares	Sole	2023-10-19
2023-06-30	$739,770	3,332	+3.7%	Shares	Sole	2023-07-17
2023-03-31	$776,984	3,214	-6.0%	Shares	Sole	2023-04-18
2022-12-31	$897,703	3,418	—	Shares	Sole	2023-02-01
No filing history on record for this holder in this stock.